Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • From the Analyst's Couch
  • Published:

Drug discovery alliances

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Preclinical discovery alliances.

References

  1. Booth, B. From the analyst's couch: valuation with cash multiples. Nature Rev. Drug Discov. 4, 533–534 (2005).

    Article  CAS  Google Scholar 

  2. Beyond Borders: Ernst & Young Global Biotechnology Report (Ernst & Young, London, 2005).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, A., Clifford, L. Drug discovery alliances. Nat Rev Drug Discov 4, 807–808 (2005). https://doi.org/10.1038/nrd1856

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd1856

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing